Cytosorbents Return on Investment 2010-2024 | CTSO
Current and historical return on investment (ROI) values for Cytosorbents (CTSO) over the last 10 years.
| Cytosorbents ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-12-31 |
$-0.02B |
$0.03B |
-62.14% |
| 2024-09-30 |
$-0.02B |
$0.03B |
-84.62% |
| 2024-06-30 |
$-0.03B |
$0.03B |
-100.00% |
| 2024-03-31 |
$-0.03B |
$0.02B |
-117.17% |
| 2023-12-31 |
$-0.03B |
$0.03B |
-114.29% |
| 2023-09-30 |
$-0.03B |
$0.02B |
-88.89% |
| 2023-06-30 |
$-0.03B |
$0.03B |
-116.50% |
| 2023-03-31 |
$-0.03B |
$0.03B |
-167.57% |
| 2022-12-31 |
$-0.03B |
$0.04B |
-310.00% |
| 2022-09-30 |
$-0.04B |
|
0.00% |
| 2022-06-30 |
$-0.03B |
|
0.00% |
| 2022-03-31 |
$-0.03B |
|
0.00% |
| 2021-12-31 |
$-0.02B |
|
0.00% |
| 2021-09-30 |
$-0.02B |
|
0.00% |
| 2021-06-30 |
$-0.01B |
|
-60.47% |
| 2021-03-31 |
$-0.01B |
|
-36.97% |
| 2020-12-31 |
$-0.01B |
|
-26.49% |
| 2020-09-30 |
$-0.01B |
$0.09B |
-28.57% |
| 2020-06-30 |
$-0.02B |
$0.03B |
-63.37% |
| 2020-03-31 |
$-0.02B |
$0.03B |
-76.40% |
| 2019-12-31 |
$-0.02B |
$0.02B |
-95.00% |
| 2019-09-30 |
$-0.02B |
$0.02B |
-89.89% |
| 2019-06-30 |
$-0.02B |
$0.02B |
-68.00% |
| 2019-03-31 |
$-0.02B |
$0.02B |
-61.82% |
| 2018-12-31 |
$-0.02B |
$0.03B |
-57.66% |
| 2018-09-30 |
$-0.01B |
$0.03B |
-55.45% |
| 2018-06-30 |
$-0.01B |
$0.03B |
-59.77% |
| 2018-03-31 |
$-0.01B |
$0.02B |
-61.11% |
| 2017-12-31 |
$-0.01B |
$0.02B |
-80.00% |
| 2017-09-30 |
$-0.01B |
$0.02B |
-112.82% |
| 2017-06-30 |
$-0.01B |
$0.02B |
-151.72% |
| 2017-03-31 |
$-0.01B |
$0.00B |
-218.18% |
| 2016-12-31 |
$-0.01B |
$0.01B |
-240.00% |
| 2016-09-30 |
$-0.01B |
$0.01B |
-266.67% |
| 2016-06-30 |
$-0.01B |
$0.01B |
-444.44% |
| 2016-03-31 |
$-0.01B |
|
0.00% |
| 2015-12-31 |
$-0.01B |
|
0.00% |
| 2015-09-30 |
$-0.01B |
|
0.00% |
| 2015-06-30 |
$-0.01B |
|
0.00% |
| 2015-03-31 |
$-0.01B |
|
0.00% |
| 2014-12-31 |
$-0.01B |
|
0.00% |
| 2014-09-30 |
$0.00B |
|
0.00% |
| 2014-06-30 |
$0.00B |
|
0.00% |
| 2014-03-31 |
$0.00B |
|
0.00% |
| 2013-12-31 |
$0.00B |
|
0.00% |
| 2013-09-30 |
$0.00B |
|
0.00% |
| 2013-06-30 |
$0.00B |
|
0.00% |
| 2013-03-31 |
$0.00B |
|
0.00% |
| 2012-12-31 |
$0.00B |
|
0.00% |
| 2012-09-30 |
$0.00B |
|
-1600.00% |
| 2012-06-30 |
$0.00B |
|
-800.00% |
| 2012-03-31 |
$0.00B |
|
-400.00% |
| 2011-12-31 |
$0.00B |
$0.00B |
-266.67% |
| 2011-09-30 |
$0.00B |
$0.00B |
-200.00% |
| 2011-06-30 |
$0.00B |
$0.00B |
-240.00% |
| 2011-03-31 |
$0.00B |
$0.00B |
-400.00% |
| 2010-12-31 |
$0.00B |
$0.00B |
-1200.00% |
| 2010-09-30 |
$0.00B |
|
0.00% |
| 2010-06-30 |
$0.00B |
|
0.00% |
| 2010-03-31 |
$0.00B |
|
0.00% |
| 2009-12-31 |
$0.00B |
|
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.051B |
$0.036B |
|
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
|
